Researchers are working on ways to neutralize cells attacking the brain, spine and brain cells in harmful ways in the disease multiple sclerosis.
The study results published in the Journal of Experimental Medicine, found the involvement of a molecule in the development of multiple sclerosis, an autoimmune disease that attacks the central nervous system.
The team of researcher led by Steve Lacroix, professor of molecular medicine, focused on one of the mechanisms that characterize multiple sclerosis, the massive influx of immune cells in the brain and spinal cord.
The researchers found that the interleukin IL-1 beta molecule was important in the development of brain inflammation and autoimmunity.
In the mouse study, it was discovered that when this molecule is blocked, rodents do not develop multiple sclerosis.
Lacroix said deleting the gene of interest, the famous immune cells that attack the brain, spinal cord, neurons, myelin (a kind of sheath that protects neurons) are unable to enter the central nervous system and cause death and permanent damage to nerve cells.
The massive influx of immune cells in the central nervous system is associated with the appearance of plaques around nerves and neurons, causing cognitive and motor disorders in multiple sclerosis.
The discovery of the involvement of interleukin IL-1 beta offers a glimpse of hope and allows treatment options.
Read Full Article: Promising Discovery for Multiple Sclerosis – ScienceNewsHub
|Read Full Article: Promising Discovery for Multiple Sclerosis – ScienceNewsHub|